Fortitude Mining Proposes Merger With HeartSciences, Stock Soars 300%

Digital Currency Group subsidiary Fortitude Mining, a private Zcash mining operation, has proposed a merger with micro-cap medical device firm HeartSciences Inc. The announcement on June 23 sent HeartSciences' Nasdaq-listed shares soaring over 300% in the pre-market session, a stark contrast to ZEC's 18% decline over the prior month. This move represents a significant attempt by a crypto-native firm to gain a traditional equity listing through a reverse merger.

Context — why this matters now

The proposed merger arrives during a period of intense pressure on cryptocurrency mining profitability. Bitcoin network hash rates near all-time highs have compressed margins across the sector, forcing miners to seek innovative financing structures. Public market valuations for pure-play crypto miners have contracted by an average of 45% year-to-date, making traditional IPOs a less viable path to capital.

This transaction follows a precedent set by other crypto firms seeking public listings. In August 2025, Bitcoin miner GRIID Infrastructure completed a SPAC merger to list on the Nasdaq, though its shares subsequently declined 60% from the debut price. The current macro backdrop of elevated interest rates has made capital-intensive mining operations increasingly dependent on equity financing for survival and growth.

The immediate catalyst is Fortitude Mining's strategic need to access public markets. As a subsidiary of Digital Currency Group, which itself has faced liquidity challenges throughout 2026, Fortitude requires a sustainable capital structure to fund ongoing operations and expansion. The merger with an existing Nasdaq-listed shell provides a faster route to public markets than a traditional IPO process.

Data — what the numbers show

HeartSciences Inc. (NASDAQ: HSCS) experienced unprecedented trading volume following the merger announcement. The stock surged from a previous close of $0.42 to a pre-market high of $1.68, representing a 300% single-session gain. Trading volume reached 18.4 million shares in the pre-market session alone, dramatically exceeding its 30-day average volume of 121,000 shares.

The company's market capitalization expanded from approximately $4.2 million to nearly $17 million based on pre-market trading levels. This valuation surge occurred despite HeartSciences reporting minimal revenue over the past four quarters, with total revenue of just $127,000 in its most recent fiscal year. The medical device firm reported a net loss of $3.8 million for the same period.

By comparison, the Nasdaq Composite Index has gained 8.7% year-to-date, while the VanEck Digital Assets Mining ETF (DAM) has declined 22% over the same period. Zcash (ZEC), the cryptocurrency mined by Fortitude, trades at $21.40, down 18% over the past 30 days despite Bitcoin's relative stability around $59,000.

Analysis — what it means for markets / sectors / tickers

The proposed merger creates immediate second-order effects across several market segments. Publicly-traded micro-cap and nanocap companies with clean corporate structures and minimal liabilities, particularly in the healthcare technology sector, may see increased investor attention as potential merger targets. This could benefit similar shell companies like Biostax (BTXA) and AppYea (APYP), which trade with market capitalizations under $10 million.

The transaction presents execution risk, as regulatory approval for such cross-sector mergers is not guaranteed. The SEC has increased scrutiny of reverse mergers involving crypto companies following several high-profile failures in 2024-2025. existing HeartSciences shareholders may face significant dilution depending on the final merger terms, which have not yet been disclosed.

Trading flow indicates speculative retail investors are driving the initial price movement, with institutional participants remaining on the sidelines pending further details. Short interest in HSCS was negligible prior to the announcement at just 0.2% of float, suggesting the rally is primarily fueled by new long positioning rather than a short squeeze.

Outlook — what to watch next

Market participants should monitor several near-term catalysts that will determine the merger's viability. HeartSciences must file a definitive merger agreement with the SEC within 45 days, typically including detailed financial information about Fortitude Mining. Shareholder approval votes typically occur 60-90 days after the initial announcement, making late August to September a critical window.

The Nasdaq listing qualification review represents another key hurdle, as exchange officials must approve the combined entity's listing application. Technical traders will watch for support at the $0.90 level, which represents a 100% retracement of the pre-market gap, and resistance near the $1.70 pre-market high.

ZEC price action following the merger announcement warrants attention, as successful access to public equity markets could improve mining economics and potentially reduce selling pressure from mining operations. The next Zcash network upgrade, scheduled for implementation in Q4 2026, may also impact mining profitability calculations.

Frequently Asked Questions

What is a reverse merger and how does it work?

A reverse merger occurs when a private company acquires a controlling interest in a publicly-traded company, effectively enabling the private firm to become public without undergoing an initial public offering. This process typically involves the public company changing its name, business focus, and management to reflect the acquiring private company. Reverse mergers can be completed more quickly than traditional IPOs but often face greater regulatory scrutiny and investor skepticism.

How does this merger affect current HeartSciences shareholders?

Existing HeartSciences shareholders will likely experience significant dilution depending on the exchange ratio established in the merger agreement. Typically, the private company's shareholders receive the majority of shares in the combined entity, reducing the ownership percentage of original public company shareholders. The final impact will depend on the relative valuations assigned to both companies and the structure of the transaction.

Why would a crypto miner merge with a medical device company?

The merger is primarily about accessing public markets rather than operational overlap. HeartSciences provides a Nasdaq listing shell with minimal liabilities, enabling Fortitude Mining to bypass the lengthy and expensive traditional IPO process. This structure allows crypto companies to access public equity markets more quickly, though regulators often scrutinize such cross-industry combinations for compliance issues.

Bottom Line

A DCG mining subsidiary seeks public markets access through an unconventional reverse merger structure.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.